CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma - FullText - GE - Portuguese Journal of Gastroenterology 2017, Vol. 24, No. 3 - Karger Publishers
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma - FullText - GE - Portuguese Journal of Gastroenterology 2017, Vol. 24, No. 3 - Karger Publishers
Univariate analysis of CA 19-9 and CEA as a categorical variable | Download Table
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
Combinatorial Serum Markers for CCA Diagnosis | Download Scientific Diagram
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
CA 19-9 Antigen - an overview | ScienceDirect Topics
Cancers | Free Full-Text | Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma - ScienceDirect
Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging | SpringerLink
Prognostic factors for operable biliary tract cancer: serum levels of | OTT
PDF) CA 19?9 and CE A are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis | Einar Björnsson - Academia.edu
Tumor marker analysis in the cases with and without cholangiocarcinoma | Download Table
Causative conditions of elevated CA 19-9 levels in the elevated CA 19-9... | Download Scientific Diagram
Diagnostic Role of Serum CA 19-9 for Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis - ScienceDirect
Cancers | Free Full-Text | The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. - Abstract - Europe PMC
PDF) CA 242, a new tumour marker for pancreatic cancer: A comparison with CA 19-9, CA 50 and CEA
